✦ LIBER ✦
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
✍ Scribed by Dreger, P.; Dohner, H.; Ritgen, M.; Bottcher, S.; Busch, R.; Dietrich, S.; Bunjes, D.; Cohen, S.; Schubert, J.; Hegenbart, U.; Beelen, D.; Zeis, M.; Stadler, M.; Hasenkamp, J.; Uharek, L.; Scheid, C.; Humpe, A.; Zenz, T.; Winkler, D.; Hallek, M.; Kneba, M.; Schmitz, N.; Stilgenbauer, S.
- Book ID
- 118269167
- Publisher
- American Society of Hematology
- Year
- 2010
- Tongue
- English
- Weight
- 326 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0006-4971
No coin nor oath required. For personal study only.